Zelnorm (tegaserod) is back, but only for certain patients
Zelnorm (tegaserod) is back, but only for certain patients.
It's for women under 55 with chronic idiopathic constipation or irritable bowel syndrome with constipation who haven't responded to other treatments...or who were helped with Zelnorm in the past.
And these patients can't be at risk for cardiovascular disease.
Get concise, unbiased advice for effective drug therapy, plus CE/CME
Prescriber Insights: APRN includes:
- Cutting-edge advice about new medications and how they fit into practice
- Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
- Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations
Already a subscriber? Log in
Volume pricing available. Get a quote